It is a pharma private limited company based in Pune, Maharashtra, India, established in 2017.
2017 | Pune, Maharashtra, India | ActiveLamium Pharmaceuticals Private Limited, a active private limited company, was established on 17 November 2017 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999PN2017PTC173456. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vijaykumar Ramrao Mangrule (Director), Sadashiv Ramrao Mangrule (Director). Past directors included Shivshankar Damodar Survase, Prasad Amarkant Kharosekar, Sadashiv Ramrao Mangrule. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 555 Bajare Mala Vadki Haveli, Pune, Maharashtra, 412307.
U74999PN2017PTC173456
173456
17 November 2017
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Lamium Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaykumar Ramrao Mangrule | Director | 17 Nov 2017 | Current |
| Sadashiv Ramrao Mangrule | Director | 26 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Dec 2018 | Past |
| Pramod Abcsdd | Director | 19 Sep 2020 | Past |
| Pramod Abcsdd | Director | 11 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lamium Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.26% increase. The company also saw a substantial improvement in profitability, with a 616.58% increase in profit. The company's net worth Soared by an impressive increase of 260.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Lamium Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lamium Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lamium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lamium Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lamium Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Lamium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on Sadashiv Ramrao Mangrule was appointed as a Director was appointed as a Director on 26 Aug 2021 & has been associated with this company since 4 years 3 months . was documented.
The activity Vijaykumar Ramrao Mangrule was appointed as a Director was appointed as a Director on 17 Nov 2017 & has been associated with this company since 8 years 15 days . was completed.
Lamium Pharmaceuticals Private Limited was registered on 17 Nov 2017 with Roc Pune & aged 8 years 15 days as per MCA records. was recorded as a recent event.
The CIN of Lamium Pharmaceuticals Private Limited is U74999PN2017PTC173456.
Lamium Pharmaceuticals Private Limited is headquartered at 555 Bajare Mala Vadki Haveli, Pune, Maharashtra, 412307.
Lamium Pharmaceuticals Private Limited was incorporated on 17 November 2017.
The current directors of Lamium Pharmaceuticals Private Limited are
The primary industry of Lamium Pharmaceuticals Private Limited is Trade.
Lamium Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lamium Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Lamium Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX